Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.45 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.45 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.45 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.45 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.45 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.45 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.45 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16071190 | 1.00 | NPSR1 (0.60) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL17870938 | 0.83 | MMP2 (0.62) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL17870939 | 0.83 | MMP2 (0.62) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL16056291 | 0.83 | L3MBTL1 (0.47) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL18264405 | 0.79 | MEN1 (0.51) | NPSR1MMP2MAPTALDH1A1GAA | |
| SCHEMBL28149879 | 0.78 | NPSR1 (0.59) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL6177618 | 0.77 | PSEN1 (0.69) | NPSR1MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL6177624 | 0.77 | PSEN1 (0.69) | NPSR1MAPTALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL14068809 | 0.74 | NPSR1 (0.61) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL16056695 | 0.74 | MMP2 (0.57) | NPSR1MMP2MAPTALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9505718-B2 | 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-11-29 | — | — | US | disclosed |
| US-9505718-B2 | 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-11-29 | — | — | US | disclosed |
| US-9505718-B2 | 3-piperidone compounds and their use as neurokinin-1 (NK1) receptor antagonists | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-11-29 | — | — | US | disclosed |
| US-20160031817-A1 | 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-02-04 | — | — | US | disclosed |
| US-20160031817-A1 | 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-02-04 | — | — | US | disclosed |
| US-20160031817-A1 | 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160031817-A1 | 3-PIPERIDONE COMPOUNDS AND THEIR USE AS NEUROKININ-1 (NK1) RECEPTOR ANTAGONISTS | TACR1, NPSR1, TACR2 | NPSR1 2/4885MMP2 3367/4885MAPT 3485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.